Athena Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 65.00 Cr
- Paid Up Capital ₹ 63.81 Cr
- Company Age 11 Year, 18 Days
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -86.25%
- Profit Growth 85.00%
- Ebitda 87.95%
- Net Worth -9.29%
- Total Assets -30.79%
About Athena Lifesciences
Athena Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 January 2014 and has a history of 11 years. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 65.00 Cr and a paid-up capital of Rs 63.81 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prabhu Karthikeyan and Bharatkumar Zinzuvadia serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233MH2014PTC315619
-
Company No.
315619
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
15 Jan 2014
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Athena Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prabhu Karthikeyan
|
Director | 01-Jul-2023 | Current |
|
Bharatkumar Zinzuvadia
|
Director | 19-Apr-2022 | Current |
Financial Performance of Athena Lifesciences.
Athena Lifesciences Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 86.25% decrease. The company also saw a substantial improvement in profitability, with a 85% increase in profit. The company's net worth dipped by a decrease of 9.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Athena Lifesciences?
In 2021, Athena Lifesciences had a public holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Seven Turns Private LimitedPrabhu Karthikeyan is a mutual person
-
Cura Consumer Health Private LimitedPrabhu Karthikeyan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Athena Lifesciences?
Athena Lifesciences has a workforce of 1 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Athena Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Athena Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
